» Articles » PMID: 10486356

Simultaneous Colonisation of Helicobacter Pylori with and Without Mutations in the 23S RRNA Gene in Patients with No History of Clarithromycin Exposure

Overview
Journal Gut
Specialty Gastroenterology
Date 1999 Sep 16
PMID 10486356
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It was recently reported that A to G transition mutations at positions 2143 and 2144 in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori.

Aims: To study the incidence and mechanism of development of clarithromycin resistance by analysing these mutations.

Subjects: Eighty two H pylori positive patients who had an endoscopic examination and no history of treatment with macrolide antibiotics.

Methods: Clarithromycin resistance was screened for by polymerase chain reaction-restriction fragment length polymorphism of the 23S rRNA gene coupled with antibiotic susceptibility testing. In clinical isolates with mutations or resistance, mutations in individual colonies were analysed by direct sequencing.

Results: Of the 79 amplicons (DNA fragments amplified by polymerase chain reaction), Alw26I and MboII digestion disclosed the mutation in four (5%) and one (1%) respectively. However, the Alw26I cleavage was incomplete in two of the four amplicons, as was the MboII cleavage. Individual colony analysis of the isolates with incomplete cleavage patterns showed the presence of both wild type and mutated strains in the 23S rRNA genes.

Conclusions: Both clarithromycin sensitive and resistant strains colonised in some patients with no history of exposure to macrolides. The results suggest that resistant strains may not be formed but selected by clarithromycin administration.

Citing Articles

Rifabutin for the Treatment of Infection: A Review.

Gisbert J Pathogens. 2020; 10(1).

PMID: 33379336 PMC: 7823349. DOI: 10.3390/pathogens10010015.


Analysis of Helicobacter pylori genotypes in clinical gastric wash samples.

Miyamoto S, Watanabe Y, Oikawa R, Ono S, Mabe K, Kudo T Tumour Biol. 2016; 37(8):10123-32.

PMID: 26825980 DOI: 10.1007/s13277-016-4886-4.


Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea.

Yoon K, Park S, Lee S, Kim B, Kim J J Korean Med Sci. 2014; 29(9):1240-6.

PMID: 25246742 PMC: 4168177. DOI: 10.3346/jkms.2014.29.9.1240.


Molecular Detection of Antibiotic Resistance in South African Isolates of Helicobacter pylori.

Tanih N, Ndip R Gastroenterol Res Pract. 2013; 2013:259457.

PMID: 23710166 PMC: 3655586. DOI: 10.1155/2013/259457.


Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of Helicobacter pylori.

Tanih N, Ndip L, Ndip R Ann Trop Med Parasitol. 2011; 105(3):251-9.

PMID: 21801504 PMC: 4090784. DOI: 10.1179/136485911X12899838683485.


References
1.
Clayton C, Kleanthous K, TABAQCHALI S . Detection and identification of Helicobacter pylori by the polymerase chain reaction. J Clin Pathol. 1991; 44(6):515-6. PMC: 496836. DOI: 10.1136/jcp.44.6.515. View

2.
Hulten K, Gibreel A, SKOLD O, Engstrand L . Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother. 1997; 41(11):2550-3. PMC: 164161. DOI: 10.1128/AAC.41.11.2550. View

3.
Yousfi M, Cole R, Genta R, Graham D . Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1995; 9(2):209-12. DOI: 10.1111/j.1365-2036.1995.tb00374.x. View

4.
Moayyedi P, Sahay P, Tompkins D, Axon A . Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol. 1995; 7(9):835-40. View

5.
Stone G, Shortridge D, Flamm R, Versalovic J, Beyer J, Idler K . Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter. 1996; 1(4):227-8. DOI: 10.1111/j.1523-5378.1996.tb00043.x. View